Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Surgery. 2016 Apr 11;160(1):67–73. doi: 10.1016/j.surg.2016.02.029

Table 3. Outcome/Survival.

Simultaneous Staged p-value
Survival
 Overall median 47 months 48 months
 Overall 12 months 90.5% 92.6%
 Overall 60 months 38.5% 38.9% 0.52
 DFS 12 months 51.5% 72.5%
 DFS 60 months 25.3% 24.3% 0.09
Site of initial recurrence
 Patients 269 89
 Liver 134 (49.8%) 38 (42.7%)
 Lung 68 (25.3%) 24 (27.0%)
 Lung and liver 23 (8.6%) 8 (9.0%)
 Peritoneal/intestine 35 (13.0%) 15 (16.8%)
 Other 9 (3.3%) 4 (4.5%) 0.79

DFS, disease-free survival.